An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.
Bcg Vaccine has been studied across 12 research domains including 🛡️ Immunity, 🔬 Oncology, 🫁 Respiratory, ✨ Skin & Hair, 🔬 Inflammation. The primary research focus is 🛡️ Immunity with 32% of studies addressing this area.
This evidence profile for Bcg Vaccine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.